Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD
Substantive evidence demonstrates the contribution of mitochondrial dysfunction in the etiology and pathogenesis of Age-related Macular Degeneration (AMD). Recently, extensive characterization of Mitochondrial‑Derived Peptides (MDPs) has revealed their cytoprotective role in several diseases, includ...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1102 |
id |
doaj-fcc8b07b306e48d4b33c5980cba4c3da |
---|---|
record_format |
Article |
spelling |
doaj-fcc8b07b306e48d4b33c5980cba4c3da2020-11-25T02:36:29ZengMDPI AGCells2073-44092020-04-0191102110210.3390/cells9051102Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMDSonali Nashine0M. Cristina Kenney1Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA 92697, USADepartment of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA 92697, USASubstantive evidence demonstrates the contribution of mitochondrial dysfunction in the etiology and pathogenesis of Age-related Macular Degeneration (AMD). Recently, extensive characterization of Mitochondrial‑Derived Peptides (MDPs) has revealed their cytoprotective role in several diseases, including AMD. Here we summarize the varied effects of MDPs on cellular and mitochondrial health, which establish the merit of MDPs as therapeutic targets for AMD. We argue that further research to delve into the mechanisms of action and delivery of MDPs may advance the field of AMD therapy.https://www.mdpi.com/2073-4409/9/5/1102MDPsmitochondrial-derived peptidesHumaninHNGSHLPsMOTS-c |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sonali Nashine M. Cristina Kenney |
spellingShingle |
Sonali Nashine M. Cristina Kenney Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD Cells MDPs mitochondrial-derived peptides Humanin HNG SHLPs MOTS-c |
author_facet |
Sonali Nashine M. Cristina Kenney |
author_sort |
Sonali Nashine |
title |
Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD |
title_short |
Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD |
title_full |
Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD |
title_fullStr |
Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD |
title_full_unstemmed |
Effects of Mitochondrial-Derived Peptides (MDPs) on Mitochondrial and Cellular Health in AMD |
title_sort |
effects of mitochondrial-derived peptides (mdps) on mitochondrial and cellular health in amd |
publisher |
MDPI AG |
series |
Cells |
issn |
2073-4409 |
publishDate |
2020-04-01 |
description |
Substantive evidence demonstrates the contribution of mitochondrial dysfunction in the etiology and pathogenesis of Age-related Macular Degeneration (AMD). Recently, extensive characterization of Mitochondrial‑Derived Peptides (MDPs) has revealed their cytoprotective role in several diseases, including AMD. Here we summarize the varied effects of MDPs on cellular and mitochondrial health, which establish the merit of MDPs as therapeutic targets for AMD. We argue that further research to delve into the mechanisms of action and delivery of MDPs may advance the field of AMD therapy. |
topic |
MDPs mitochondrial-derived peptides Humanin HNG SHLPs MOTS-c |
url |
https://www.mdpi.com/2073-4409/9/5/1102 |
work_keys_str_mv |
AT sonalinashine effectsofmitochondrialderivedpeptidesmdpsonmitochondrialandcellularhealthinamd AT mcristinakenney effectsofmitochondrialderivedpeptidesmdpsonmitochondrialandcellularhealthinamd |
_version_ |
1724799921395073024 |